PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
TMDPX
Price
$16.03
Change
+$0.12 (+0.75%)
Updated
Jun 2 closing price
Net Assets
1.64B
Interact to see
Advertisement

PMBCX vs TMDPX

Header iconPMBCX vs TMDPX Comparison
Open Charts PMBCX vs TMDPXBanner chart's image
PMBCX vs TMDPX Comparison Chart in %
View a ticker or compare two or three
VS
PMBCX vs. TMDPX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBCX is a Buy and TMDPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. TMDPX (1.64B). PMBCX (0.00) and TMDPX (0.00) have matching dividends . PMBCX was incepted earlier than TMDPX: PMBCX (19 years) vs TMDPX (21 years). PMBCX (1.71) is less costly to investors than TMDPX (1.06). TMDPX is a more actively managed with annual turnover of: 50.00 vs. PMBCX (13.70). PMBCX has a lower initial minimum investment than TMDPX: PMBCX (1000) vs TMDPX (2000). TMDPX annual gain was more profitable for investors over the last year : -3.93 vs. PMBCX (-15.11). PMBCX return over 5 years is better than : -9.16 vs. TMDPX (-21.66).
PMBCXTMDPXPMBCX / TMDPX
Total Expense Ratio1.711.06161%
Annual Report Gross Expense Ratio1.711.06161%
Fund Existence19 years21 years-
Gain YTD-7.2524.191-173%
Front LoadN/AN/A-
Min. Initial Investment1000200050%
Min. Initial Investment IRAN/AN/A-
Net Assets24.6B1.64B1,502%
Annual Yield % from dividends0.000.00-
Returns for 1 year-15.11-3.93385%
Returns for 3 years9.9712.6079%
Returns for 5 years-9.16-21.6642%
Returns for 10 years53.20-10.27-518%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity